pyridoxamine has been researched along with Cardiac Failure in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pyridoxamine was used as the antagonist of advanced glycation end products (AGEs)." | 1.42 | Advanced glycation end products induced immune maturation of dendritic cells controls heart failure through NF-κB signaling pathway. ( Cao, W; Chen, J; Chen, S; Chen, X; Chen, Y; Huang, H; Liu, P, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, W | 1 |
| Chen, J | 1 |
| Chen, Y | 1 |
| Chen, S | 1 |
| Chen, X | 1 |
| Huang, H | 1 |
| Liu, P | 1 |
1 other study available for pyridoxamine and Cardiac Failure
| Article | Year |
|---|---|
Advanced glycation end products induced immune maturation of dendritic cells controls heart failure through NF-κB signaling pathway.
Topics: Animals; Bone Marrow; Cardiotonic Agents; Cell Differentiation; Coculture Techniques; Dendritic Cell | 2015 |